Viewing Study NCT00330018


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2026-02-20 @ 10:12 PM
Study NCT ID: NCT00330018
Status: COMPLETED
Last Update Posted: 2015-04-21
First Post: 2006-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)
Sponsor: Hadassah Medical Organization
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module